(a) Each dispenser shall, regarding each controlled substance dispensed, submit to the committee all of the following information by a procedure and in a format established by the committee at least monthly within ten (10) days following the last day of each calendar month:
(1) Prescriber identifier;
(2) Dispensing date of controlled substance;
(3) Patient identifier;
(4) Controlled substance dispensed identifier;
(5) Quantity of controlled substance dispensed;
(6) Strength of controlled substance dispensed;
(7) Estimated days supply;
(8) Dispenser identifier; and
(9) Other relevant information as required by rule.
(b) A pharmacy dispenser that uses a computerized system to record information concerning the dispensing of controlled substances listed in Schedule II, III, or IV, and Schedule V controlled substances identified by the controlled substance database advisory committee as demonstrating a potential for abuse, shall submit the required information to the committee or its agent utilizing nationally recognized pharmacy telecommunications format standards.
(c) The board of pharmacy shall maintain the database in an electronic file or by other means established by the committee in such a manner as not to infringe on the legal use of controlled substances, and in such a manner as to facilitate use of the database for identification of:
(1) Prescribing practices and patterns of prescribing and dispensing controlled substances; and
(2) Individuals, facilities or entities receiving prescriptions for controlled substances from licensed practitioners, and who subsequently obtain dispensed controlled substances from a pharmacy in quantities or with a frequency inconsistent with generally recognized standards of dosage for that controlled substance, or by means of forged or otherwise false or altered prescriptions.
(d) (1) The committee shall by rule establish the electronic format in which the information required under this section shall be submitted to the committee and shall allow for waiver for individual dispensers for whom it would cause undue hardship.
(2) The committee shall ensure the database system records and shall maintain for reference:
(A) Identification of each person who requests or receives information from the database;
(B) The information provided to each person; and
(C) The date and time the information is requested or provided.
(e) The committee shall make rules to:
(1) Effectively enforce the limitations on access to the database as described in this part; and
(2) Establish standards and procedures to ensure accurate identification of individuals requesting information or receiving information from the database without a request.
(a) Each dispenser shall, regarding each controlled substance dispensed, submit to the committee all of the following information by a procedure and in a format established by the committee at least monthly within ten (10) days following the last day of each calendar month:
(1) Prescriber identifier;
(2) Dispensing date of controlled substance;
(3) Patient identifier;
(4) Controlled substance dispensed identifier;
(5) Quantity of controlled substance dispensed;
(6) Strength of controlled substance dispensed;
(7) Estimated days supply;
(8) Dispenser identifier; and
(9) Other relevant information as required by rule.
(b) A pharmacy dispenser that uses a computerized system to record information concerning the dispensing of controlled substances listed in Schedule II, III, or IV, and Schedule V controlled substances identified by the controlled substance database advisory committee as demonstrating a potential for abuse, shall submit the required information to the committee or its agent utilizing nationally recognized pharmacy telecommunications format standards.
(c) The board of pharmacy shall maintain the database in an electronic file or by other means established by the committee in such a manner as not to infringe on the legal use of controlled substances, and in such a manner as to facilitate use of the database for identification of:
(1) Prescribing practices and patterns of prescribing and dispensing controlled substances; and
(2) Individuals, facilities or entities receiving prescriptions for controlled substances from licensed practitioners, and who subsequently obtain dispensed controlled substances from a pharmacy in quantities or with a frequency inconsistent with generally recognized standards of dosage for that controlled substance, or by means of forged or otherwise false or altered prescriptions.
(d) (1) The committee shall by rule establish the electronic format in which the information required under this section shall be submitted to the committee and shall allow for waiver for individual dispensers for whom it would cause undue hardship.
(2) The committee shall ensure the database system records and shall maintain for reference:
(A) Identification of each person who requests or receives information from the database;
(B) The information provided to each person; and
(C) The date and time the information is requested or provided.
(e) The committee shall make rules to:
(1) Effectively enforce the limitations on access to the database as described in this part; and
(2) Establish standards and procedures to ensure accurate identification of individuals requesting information or receiving information from the database without a request.
(a) Each dispenser shall, regarding each controlled substance dispensed, submit to the committee all of the following information by a procedure and in a format established by the committee at least monthly within ten (10) days following the last day of each calendar month:
(1) Prescriber identifier;
(2) Dispensing date of controlled substance;
(3) Patient identifier;
(4) Controlled substance dispensed identifier;
(5) Quantity of controlled substance dispensed;
(6) Strength of controlled substance dispensed;
(7) Estimated days supply;
(8) Dispenser identifier; and
(9) Other relevant information as required by rule.
(b) A pharmacy dispenser that uses a computerized system to record information concerning the dispensing of controlled substances listed in Schedule II, III, or IV, and Schedule V controlled substances identified by the controlled substance database advisory committee as demonstrating a potential for abuse, shall submit the required information to the committee or its agent utilizing nationally recognized pharmacy telecommunications format standards.
(c) The board of pharmacy shall maintain the database in an electronic file or by other means established by the committee in such a manner as not to infringe on the legal use of controlled substances, and in such a manner as to facilitate use of the database for identification of:
(1) Prescribing practices and patterns of prescribing and dispensing controlled substances; and
(2) Individuals, facilities or entities receiving prescriptions for controlled substances from licensed practitioners, and who subsequently obtain dispensed controlled substances from a pharmacy in quantities or with a frequency inconsistent with generally recognized standards of dosage for that controlled substance, or by means of forged or otherwise false or altered prescriptions.
(d) (1) The committee shall by rule establish the electronic format in which the information required under this section shall be submitted to the committee and shall allow for waiver for individual dispensers for whom it would cause undue hardship.
(2) The committee shall ensure the database system records and shall maintain for reference:
(A) Identification of each person who requests or receives information from the database;
(B) The information provided to each person; and
(C) The date and time the information is requested or provided.
(e) The committee shall make rules to:
(1) Effectively enforce the limitations on access to the database as described in this part; and
(2) Establish standards and procedures to ensure accurate identification of individuals requesting information or receiving information from the database without a request.
